The expression of GGCT in the bladder urothelial cell carcinoma and its clinical significance
10.3760/cma.j.cn112152-20200326-00264
- VernacularTitle:膀胱尿路上皮癌组织中γ-谷氨酰环化转移酶的表达及其临床意义
- Author:
Yongshun GUO
1
;
Yudong WU
;
Hao MA
;
Lei QI
;
Shidong ZHANG
;
Yunjiang ZANG
Author Information
1. 山东省潍坊市人民医院泌尿外科 261041
- Keywords:
Bladder urothelial cell carcinoma;
γ-Glutamylcyclotransferase;
Immunohistochemistry staining;
Prognosis
- From:
Chinese Journal of Oncology
2021;43(11):1183-1187
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the expression and clinical significance of γ-glutamylcyclotransferase (GGCT) in patients with bladder urothelial cell carcinoma.Methods:Immunohistochemical staining for GGCT were performed on tissue sections of 86 patients with bladder urothelial cell carcinoma and 10 normal controls, and the correlations between GGCT and clinicopathological characteristics and the prognosis were analyzed.Results:The positive rate of the expression of GGCT in 86 cases of bladder urothelial cell carcinoma was 61.6% (53/86). GGCT protein was located mainly in cancer cell cytoplasm, and it can be seen in the nucleus of the tumor cells in some cases. The level of GGCT expression was positively related to pathological classification ( P<0.001), stage ( P=0.020), and tumor size ( P=0.025). Immunohistochemical semiquantitative analysis showed that the expression of GGCT in patients with T1 stage of non-muscle invasion bladder urothelial cell carcinoma was significantly higher than that with Ta stage ( P=0.034). Kaplan-Meier analysis showed that the expression of GGCT was correlated with the recurrence-free survival in patients with non-muscle invasive bladder cancer, the recurrence-free survival rate was lower in the GGCT positive group ( P=0.029). Multivariate COX regression analysis showed that the pathological stage ( OR=5.029, P=0.009) and the number of tumors ( OR=3.320, P=0.024)were the independent risk factors for recurrence-free survival in patients with early urothelial cell carcinoma of the bladder. Conclusions:The expression of GGCT is significantly increased in bladder urothelial cell carcinoma and is related to the malignant biological behavior and progression of tumor. Patients with GGCT positive early bladder tumor are inclined to recur.
